alexa The Facts And Figures For Middle East And North Africa (MENA) Region: A Strategic Component Of Global Clinical Trials
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Pharmaceutical Regulatory Affairs
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Satish Chandra-Nair
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.012
Abstract
Recent reports indicate that up to 31% of the world's clinical trials are currently being conducted outside of the US and 25% of the investigational new drug applications include data from clinical trials conducted at international study sites. The need for diverse patient population for research, decreased trial costs, improved subject accrual, and, access to rare diseases are additional driving forces for the expansion of international clinical research. The high population growth, demand for medication, improved life expectancy, increased prevalence of life-style related disease and access to rare diseases in the MENA countries should drive the conduct of clinical trials in these countries; yet the region hosts only about 0.5% of global clinical trial sites. Many factors, including the regulatory environment, patient protection, physician-preparedness, type of diseases, costs of trials and pace of subject recruitment, were analyzed to identify critical challenges and opportunities for the effective pursuit of clinical trials in the MENA region. Regulatory challenges and oversight issues can be overcome through strategic planning by the local CRO. Risk-based monitoring and education and cross training of healthcare professionals in the region can overcome barriers related to trial quality and subject protection. Population characteristics, growing healthcare infrastructure, and the state-of-the-art communication technologies provide clear advantages for clinical trial subject recruitment in the region. Low physician salaries, lower operating costs and the expected increase in pharmaceutical sales in the region are significant incentives for the future conduct of clinical trials.
Biography
Satish Chandra-Nair is the Senior Specialist and Head for Clinical Research at Tawam Hospital- Johns Hopkins Medicine International Affiliate, and Clinical Assistant professor at the Faculty of Medicine and Health Sciences, UAE University, Al Ain in the UAE. He has served as a faculty member both in US Medical Schools and in India and later as a member of senior management for pharmaceutical companies in the USA. He is a primary inventor (Immunophilin) and primary investigator and has published over 40 international peer reviewed scientific papers and presented significant number of abstracts at conferences. He has been rewarded with professional achievement awards such as the Global Leadership Award for Clinical Research by the Academy of Clinical Research, USA, Union of International Cancer Control, Japanese Cancer Foundation, and Society for Cell Differentiation young investigator award, and has been the invited reviewer for the Susan G. Komen Cancer Foundation breast cancer grants. Additionally, he is on the Editorial Advisory Board of several USA journals such as Journal of Diabetes Technology and Therapeutics, Clinical Research and Regulatory Affairs and Editor-in-Chief of Applied Clinical Trials and Clinical Research, USA. He has chaired several sessions and delivered lectures on Molecular drug discovery, Signaling pathways, Receptors and small molecule targets, Clinical Trials etc; very recently he was invited to speak at the prestigious ?Evolution Summit 2011? for Clinical Trial and Pharmaceutical Leaders in Montreux, Switzerland (2011). He is also the Chair of the Gulf Cooperation Council Chapter for the ACRP (USA).
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version